Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and observational evidence
PubMed 23696730 · doi:10.1371/journal.ppat.1003327
What was done
This narrative review synthesizes epidemiological findings and molecular research to describe how human hemoglobin variants (HbS, HbC, and alpha-thalassemia) protect against severe Plasmodium falciparum malaria and illuminate parasite pathogenesis pathways.
What was found
Heterozygous HbS (sickle-cell trait) and homozygous HbC reduce the risk of severe falciparum malaria by 90% and 70%, respectively, in African children. Protection applies selectively to severe disease rather than preventing initial parasite infection. Mechanistically, these variants impair parasite growth (potentially via host microRNA interference with parasite metabolism), disrupt the export of P. falciparum erythrocyte membrane protein 1 (PfEMP1) to the red blood cell surface, and may involve heme oxygenase-1 pathways.
Why it matters
Elucidating how natural hemoglobin variants selectively prevent life-threatening malaria clarifies the essential virulence mechanisms of P. falciparum, providing molecular targets for future antimalarial therapies and preventive interventions.
Limits
The abstract presents a narrative synthesis without original data, systematic search criteria, or statistical measures of uncertainty (such as confidence intervals). Specific quantitative risk reductions for alpha-thalassemia are not provided in the abstract, and some mechanistic findings rely on animal models.
Cited by
- supports Being a heterozygote for the sickle cell anemia mutation confers a survival advantage against malaria.